1. Home
  2. EDSA vs FMST Comparison

EDSA vs FMST Comparison

Compare EDSA & FMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • FMST
  • Stock Information
  • Founded
  • EDSA 2015
  • FMST 2005
  • Country
  • EDSA Canada
  • FMST Canada
  • Employees
  • EDSA N/A
  • FMST N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • FMST Other Metals and Minerals
  • Sector
  • EDSA Health Care
  • FMST Basic Materials
  • Exchange
  • EDSA Nasdaq
  • FMST Nasdaq
  • Market Cap
  • EDSA 6.2M
  • FMST 7.1M
  • IPO Year
  • EDSA N/A
  • FMST N/A
  • Fundamental
  • Price
  • EDSA $2.45
  • FMST $0.78
  • Analyst Decision
  • EDSA Strong Buy
  • FMST
  • Analyst Count
  • EDSA 1
  • FMST 0
  • Target Price
  • EDSA $21.00
  • FMST N/A
  • AVG Volume (30 Days)
  • EDSA 32.2K
  • FMST 53.7K
  • Earning Date
  • EDSA 05-09-2025
  • FMST 01-01-0001
  • Dividend Yield
  • EDSA N/A
  • FMST N/A
  • EPS Growth
  • EDSA N/A
  • FMST N/A
  • EPS
  • EDSA N/A
  • FMST N/A
  • Revenue
  • EDSA N/A
  • FMST N/A
  • Revenue This Year
  • EDSA N/A
  • FMST N/A
  • Revenue Next Year
  • EDSA N/A
  • FMST N/A
  • P/E Ratio
  • EDSA N/A
  • FMST N/A
  • Revenue Growth
  • EDSA N/A
  • FMST N/A
  • 52 Week Low
  • EDSA $1.55
  • FMST $0.55
  • 52 Week High
  • EDSA $5.59
  • FMST $3.48
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 53.34
  • FMST 42.90
  • Support Level
  • EDSA $2.31
  • FMST $0.78
  • Resistance Level
  • EDSA $2.55
  • FMST $0.90
  • Average True Range (ATR)
  • EDSA 0.12
  • FMST 0.09
  • MACD
  • EDSA -0.02
  • FMST 0.02
  • Stochastic Oscillator
  • EDSA 48.28
  • FMST 58.64

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About FMST Foremost Lithium Resource & Technology Ltd. Common stock

Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with significant historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec.

Share on Social Networks: